{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T17:31:52Z","timestamp":1650389512003},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/bf02940305","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T18:01:03Z","timestamp":1231524063000},"page":"276-283","source":"Crossref","is-referenced-by-count":4,"title":["Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier"],"prefix":"10.1007","volume":"13","author":[{"given":"Stephen G.","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubina","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Cerceo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy S.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean J.","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02940305_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc970","volume":"3","author":"AD D\u2019Andrea","year":"2003","unstructured":"D\u2019Andrea AD, Grompe M: The Fanconi anaemia\/BRCA pathway. Nat Rev Cancer 3: 23\u201334, 2003","journal-title":"Nat Rev Cancer"},{"key":"BF02940305_CR2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","volume":"297","author":"NG Howlett","year":"2002","unstructured":"Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De DieSmulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D\u2019Andrea AD: Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606\u2013609, 2002","journal-title":"Science"},{"key":"BF02940305_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.0.CO;2-H","volume":"10","author":"N Papadopoulos","year":"1997","unstructured":"Papadopoulos N, Lindblom A: Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10: 89\u201399, 1997","journal-title":"Hum Mutat"},{"key":"BF02940305_CR4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0092-8674(92)90243-6","volume":"70","author":"LR Livingstone","year":"1992","unstructured":"Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923\u2013935, 1992","journal-title":"Cell"},{"key":"BF02940305_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09553000110097974","volume":"78","author":"B Nieuwenhuis","year":"2002","unstructured":"Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, Sijmons RH, Van der Hout AH, Bauch T, Streffer C, Kampinga HH: BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. Int J Radiat Biol 78: 285\u2013295, 2002","journal-title":"Int J Radiat Biol"},{"key":"BF02940305_CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0027-5107(01)00300-1","volume":"500","author":"K Trenz","year":"2002","unstructured":"Trenz K, Rothfuss A, Schutz P, Speit G: Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat Res 500: 89\u201396, 2002","journal-title":"Mutat Res"},{"issue":"Suppl 2","key":"BF02940305_CR7","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1016\/S0360-3016(03)01240-9","volume":"57","author":"H Mamon","year":"2003","unstructured":"Mamon H, Dahlberg W, Little JB: Hemizygous fibroblast cell strains established from patients with BRCA1 or BRCA2 mutations demonstrate an increased rate of spontaneous mutations and increased radiosensitivity. Int J Radiat Oncol Biol Phys 57(Suppl 2): S346-S347, 2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF02940305_CR8","first-page":"390","volume":"60","author":"A Rothfuss","year":"2000","unstructured":"Rothfuss A, Schutz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G: Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60: 390\u2013394, 2000","journal-title":"Cancer Res"},{"key":"BF02940305_CR9","first-page":"299","volume-title":"Immunobiology of Transfusion Medicine","author":"SG Grant","year":"1993","unstructured":"Grant SG, Jensen RH: Use of hematopoietic cells and markers for the detection and quantitation of humanin vivo somatic mutation. In: Immunobiology of Transfusion Medicine. (Ed: Garratty G), Marcel Dekker, New York, 1993, pp. 299\u2013323"},{"key":"BF02940305_CR10","first-page":"133","volume-title":"Late Effects of Treatment for Childhood Cancer","author":"SG Grant","year":"1992","unstructured":"Grant SG, Bigbee WL, Langlois RG, Jensen RH: Methods for the detection of mutational and segregational events: relevance to the monitoring of survivors of childhood cancer. In: Late Effects of Treatment for Childhood Cancer. (Eds: Green DM, and D\u2019Angio GJ), Wiley-Liss, New York, 1992, pp. 133\u2013150"},{"key":"BF02940305_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0027-5107(89)90096-1","volume":"210","author":"A Tompa","year":"1989","unstructured":"Tompa A, Sapi E: Detection of 6-thioguanine resistance in human peripheral blood lymphocytes (PBL) of industrial workers and lung cancer patients. Mutat Res 210: 345\u2013351, 1989","journal-title":"Mutat Res"},{"key":"BF02940305_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0027-5107(94)90320-4","volume":"304","author":"J Cole","year":"1994","unstructured":"Cole J, Skopek TR: Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res 304: 33\u2013105, 1994","journal-title":"Mutat Res"},{"key":"BF02940305_CR13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/carcin\/18.2.445","volume":"18","author":"S Okada","year":"1997","unstructured":"Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Wakabayashi K: Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma. Carcinogenesis 18: 445\u2013449, 1997","journal-title":"Carcinogenesis"},{"key":"BF02940305_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1615\/JEnvironPatholToxicolOncol.v20.i4.10","volume":"20","author":"SG Grant","year":"2001","unstructured":"Grant SG: Molecular epidemiology of human cancer: biomarkers of genotoxic exposure and susceptibility. J Environ Pathol Toxicol Oncol 20: 245\u2013261, 2001","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"BF02940305_CR15","first-page":"47","volume":"340C","author":"RG Langlois","year":"1990","unstructured":"Langlois RG, Bigbee WL, Jensen RH: The glycophorin A assay for somatic cell mutations in humans. Prog Clin Biol Res 340C: 47\u201356, 1990","journal-title":"Prog Clin Biol Res"},{"key":"BF02940305_CR16","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","volume":"325","author":"M Swift","year":"1991","unstructured":"Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiecasia. N Engl J Med 325: 1831\u20131836, 1991","journal-title":"N Engl J Med"},{"key":"BF02940305_CR17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.onc.1200818","volume":"14","author":"F Kerangueven","year":"1997","unstructured":"Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy M, Sobol H, Birnbaum D: Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 regions. Oncogene 14: 339\u2013347, 1997","journal-title":"Oncogene"},{"key":"BF02940305_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6874-6-10","volume":"6","author":"WS Rubinstein","year":"2006","unstructured":"Rubinstein WS, Latimer JJ, Sumkin JH, Huerbin M, Grant SG, Vogel VG: Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high risk women. BMC Women\u2019s Health 6: 10, 2006","journal-title":"BMC Women\u2019s Health"},{"key":"BF02940305_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2350-6-26","volume":"6","author":"JJ Latimer","year":"2005","unstructured":"Latimer JJ, Rubinstein WS, Johnson JM, Kanbour-Shakir A, Vogel VG, Grant SG: Haploinsufficiency forBRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes. BMC Med Genet 6: 26, 2005","journal-title":"BMC Med Genet"},{"key":"BF02940305_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/mutage\/2.2.87","volume":"2","author":"JP O\u2019Neill","year":"1987","unstructured":"O\u2019Neill JP, McGinniss MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ: Refinement of a T-lymphocyte cloning assay to quantify thein vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2: 87\u201394, 1987","journal-title":"Mutagenesis"},{"key":"BF02940305_CR21","first-page":"179","volume":"291","author":"SG Grant","year":"2005","unstructured":"Grant SG: TheGPA in vivo somatic mutation assay. Meth Mol Biol 291: 179\u2013195, 2005","journal-title":"Meth Mol Biol"},{"key":"BF02940305_CR22","first-page":"149","volume":"28","author":"RH Jensen","year":"1987","unstructured":"Jensen RH, Bigbee WL, Langlois RG: In vivo somatic mutations in the glycophorin A locus of human erythroid cells. Banbury Rep 28: 149\u2013159, 1987","journal-title":"Banbury Rep"},{"key":"BF02940305_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/em.2850260304","volume":"26","author":"DK Manchester","year":"1995","unstructured":"Manchester DK, Nicklas JA, O\u2019Neill JP, Lippert MJ, Grant SG, Langlois RG, Moore DH 3rd,Jensen RH, Albertini RJ, Bigbee WL: Sensitivity of somatic mutations in human umbilical cord blood to maternal environments. Environ Mol Mutagen 26: 203\u2013212, 1995","journal-title":"Environ Mol Mutagen"},{"key":"BF02940305_CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/gte.1997.1.261","volume":"1","author":"SG Grant","year":"1998","unstructured":"Grant SG, Reeger W, Wenger SL: Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay. Genet Testing 1: 261\u2013267, 1998","journal-title":"Genet Testing"},{"key":"BF02940305_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0027-5107(94)90157-0","volume":"308","author":"BA Finette","year":"1994","unstructured":"Finette BA, Sullivan LM, O\u2019Neill JP, Nicklas JA, Vacek PM, Albertini RJ: Determination ofhprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat Res 308: 223\u2013231, 1994","journal-title":"Mutat Res"},{"key":"BF02940305_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-1161(91)90133-S","volume":"253","author":"AD Tates","year":"1991","unstructured":"Tates AD, van Dam FJ, van Mossel H, schoemaker H, Thijssen JC, Woldring VM, Zwinderman AH, Natarajan AT: Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutat Res 253: 199\u2013213, 1991","journal-title":"Mutat Res"},{"key":"BF02940305_CR27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0027-5107(93)90115-V","volume":"285","author":"RF Branda","year":"1993","unstructured":"Branda RF, Sullivan LM, O\u2019Neill JP, Falta MT, Nicklas JA, Hirsch B, Vacek PM, Albertini RJ: Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat Res 285: 267\u2013279, 1993","journal-title":"Mutat Res"},{"key":"BF02940305_CR28","first-page":"249","volume":"2","author":"IM Jones","year":"1993","unstructured":"Jones IM, Moore DH, Thomas CB, Thompson CL, Strout CL, Burkhart-Schultz K: Factors affectingHPRT mutant frequency in T-lymphocytes of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 2: 249\u2013260, 1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF02940305_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0027-5107(02)00119-7","volume":"505","author":"BA Finette","year":"2002","unstructured":"Finette BA, Kendall H, Vacek PM: Mutational spectral analysis at the HPRT locus in healthy children.Mutat Res 505: 27\u201341, 2002","journal-title":"Mutat Res"},{"key":"BF02940305_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-7992(95)00050-X","volume":"348","author":"E H\u00fcttner","year":"1995","unstructured":"H\u00fcttner E, Holzapfel B, Kropf S: Frequency of HPRT mutant lymphocytes in a human control population as determined by the T-cell cloning procedure. Mutat Res 348: 83\u201391, 1995","journal-title":"Mutat Res"},{"key":"BF02940305_CR31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1383-5718(01)00182-6","volume":"494","author":"R Becker","year":"2001","unstructured":"Becker R, Nikolova T, Wolff I, Lovell D, H\u00fcttner E, Foth H: Frequency of HPRT mutants in humans exposed to vinyl chloride via an environmental accident. Mutat Res 494: 87\u201396, 2001","journal-title":"Mutat Res"},{"key":"BF02940305_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0027-5107(93)90137-5","volume":"289","author":"M Sala-Trepat","year":"1993","unstructured":"Sala-Trepat M, Boyse J, Richard P, Papadopoulo D, Moustacchi E: Frequencies ofHPRT lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors. Mutat Res 289: 115\u2013126, 1993","journal-title":"Mutat Res"},{"key":"BF02940305_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.a.30687","volume":"135","author":"VN Evdokimova","year":"2005","unstructured":"Evdokimova VN, McLoughlin RK, Wenger SL, Grant SG: Use of the glycophorin A bone marrow somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless ofGPA genotype. Am J Med Genet 135: 59\u201365, 2005","journal-title":"Am J Med Genet"},{"issue":"Suppl","key":"BF02940305_CR34","first-page":"94","volume":"75","author":"SG Grant","year":"2004","unstructured":"Grant SG, Wenger SL, Rubinstein WS, Latimer JJ, Bigbee WL, Auerbach AD: Elevated levels of somatic mutation in homozygotes and heterozygotes for inactivating mutations in the genes of the FA\/BRCA DNA repair pathway [abstract]. Am J Hum Genet 75(Suppl): 94, 2004","journal-title":"Am J Hum Genet"},{"key":"BF02940305_CR35","first-page":"264","volume":"70","author":"Vijayalaxmi","year":"1985","unstructured":"Vijayalaxmi, Wunder E, Schroeder TM: Spontaneous 6-thioguanine-resistant lymphocytes in Fanconi anemia patients and their heterozygous parents. Hum Genet 70: 264\u2013270, 1985","journal-title":"Hum Genet"},{"key":"BF02940305_CR36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0027-5107(89)90033-X","volume":"213","author":"AD Tates","year":"1989","unstructured":"Tates AD, Bernini LF, Natarajan AT, Ploem JS, Verwoerd NP, Cole J, Green MHL, Arlett CF, Norris PN: Detection of somatic mutants in man: HPRT mutations in lymphocytes and hemoglobin mutations in erythrocytes. Mutat Res 213: 73\u201382, 1989","journal-title":"Mutat Res"},{"key":"BF02940305_CR37","first-page":"25","volume":"340C","author":"J Cole","year":"1990","unstructured":"Cole J, Green MHL, Stephens G, Waugh AP, Beare D, Steingrimsdottir H, Brideges BA: HPRT somatic mutation data. Prog Clin Biol Res 340C: 25\u201335, 1990","journal-title":"Prog Clin Biol Res"},{"key":"BF02940305_CR38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/1523-1747.ep12873952","volume":"94","author":"PG Norris","year":"1990","unstructured":"Norris PG, Limb GA, Hamblin AS, Lehmann AR, Arlett CF, Cole J, Waugh AP, Hawk JL: Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne\u2019s syndrome, and trichothiodystrophy. J Invest Dermatol 94: 94\u2013100, 1990","journal-title":"J Invest Dermatol"},{"key":"BF02940305_CR39","first-page":"191","volume":"54","author":"W Vermeulen","year":"1994","unstructured":"Vermeulen W, Scott RJ, Rodgers S, Muller HJ, Cole J, Arlett CF, Kleijer WJ, Bootsma D, Hoeijmakers JH, Weeda G: Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription geneERCC3. Am J Hum Genet 54: 191\u2013200, 1994","journal-title":"Am J Hum Genet"},{"key":"BF02940305_CR40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2133.1991.tb14754.x","volume":"125","author":"AV Anstey","year":"1991","unstructured":"Anstey AV, Arlett CF, Cole J, Norris PG, Hamblin AS, Limb GA, Lehmann AR, Wilkinson JD, Turner M: Long-term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma. Br J Dermatol 125: 272\u2013278, 1991","journal-title":"Br J Dermatol"},{"key":"BF02940305_CR41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0921-8777(92)90078-H","volume":"273","author":"J Cole","year":"1992","unstructured":"Cole J, Arlett CF, Norris PG, Stephens G, Waugh AP, Beare DM, Green MHL: Elevatedhprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutat Res 273: 171\u2013178, 1992","journal-title":"Mutat Res"},{"key":"BF02940305_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0921-8777(95)00014-B","volume":"337","author":"YW Lin","year":"1995","unstructured":"Lin YW, Kubota M, Hirota H, Furusho K, Tomiwa K, Ochi J, Kasahara Y, Sasaki H, Ohta S: Somatic cell mutation frequency at the HPRT, T-cell antigen receptor and glycophorin A loci in Cockayne syndrome. Mutat Res 337: 49\u201355, 1995","journal-title":"Mutat Res"},{"key":"BF02940305_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0921-8734(95)00019-3","volume":"338","author":"M Akiyama","year":"1995","unstructured":"Akiyama M, Kyoizumi S, Hirai Y, Kusunoki Y, Iwamoto KS, Nakamura N: Mutation frequency in human blood cells increases with age. Mutat Res 338: 141\u2013149, 1995","journal-title":"Mutat Res"},{"key":"BF02940305_CR44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0047-6374(82)90046-X","volume":"19","author":"AA Morley","year":"1982","unstructured":"Morley AA, Cox S, Holliday R: Human lymphocytes resistant to 6-thioguanine increase with age. Mech Ageing Dev 19: 21\u201326, 1982","journal-title":"Mech Ageing Dev"},{"key":"BF02940305_CR45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.1992.tb38646.x","volume":"663","author":"H Vrieling","year":"1992","unstructured":"Vrieling H, Tates AD, Natarajan AT, van Zeeland AA: Age-related accumulation of mutations in human T-lymphocytes. Ann N Y Acad Sci 663: 36\u201342, 1992","journal-title":"Ann N Y Acad Sci"},{"key":"BF02940305_CR46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/em.2850190403","volume":"19","author":"RF Branda","year":"1992","unstructured":"Branda RF, O\u2019Neill JP, Jacobson-Kram D, Albertini RJ: Factors influencing mutation at thehprt locus in T-lymphocytes: studies in normal women and women with benign and malignant breast masses. Environ Mol Mutagen 19: 274\u2013281, 1992","journal-title":"Environ Mol Mutagen"},{"key":"BF02940305_CR47","first-page":"440","volume":"40","author":"JJ Latimer","year":"1999","unstructured":"Latimer JJ, Kisin E, Zayas-Rivera B, Kanbour-Shakir A, Kelley J, Johnson R, Grant SG: Increased somatic mutation and reduced DNA repair in breast cancer patients and their tumors [abstract]. Proc Am Assoc Cancer Res 40: 440, 1999","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF02940305_CR48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/em.2850180412","volume":"18","author":"JA Nicklas","year":"1991","unstructured":"Nicklas JA, Lippert MJ, Hunter TC, O\u2019Neill JP, Albertini RJ: Analysis of human HPRT deletion mutations with X-linked probes and pulsed field gel electrophoresis. Environ Mol Mutagen 18: 270\u2013273, 1991","journal-title":"Environ Mol Mutagen"},{"key":"BF02940305_CR49","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1073\/pnas.87.21.8383","volume":"87","author":"D Papadopoulo","year":"1990","unstructured":"Papadopoulo D, Guillouf C, Mohrenweiser H, Moustacchi E: Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc Natl Acad Sci USA 87: 8383\u20138387, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02940305_CR50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0027-5107(99)00177-3","volume":"431","author":"A Laquerbe","year":"1999","unstructured":"Laquerbe A, Sala-Trepat M, Vives C, Escarceller M, Papadopoulo D: Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients. Mutat Res 431: 341\u2013350, 1999","journal-title":"Mutat Res"},{"key":"BF02940305_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jcp.1040870211","volume":"87","author":"E Elmore","year":"1975","unstructured":"Elmore E, Swift M: Growth of cultured cells from patients with Fanconi anemia. J Cell Physiol 87: 229\u2013233, 1975","journal-title":"J Cell Physiol"},{"key":"BF02940305_CR52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jcp.1041010211","volume":"101","author":"R Weksberg","year":"1979","unstructured":"Weksberg R, Buchwald M, Sargent P, Thompson MW, Siminovitch L: Specific cellular defects in patients with Fanconi anemia. J Cell Physiol 101: 311\u2013323, 1979","journal-title":"J Cell Physiol"},{"key":"BF02940305_CR53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1385\/0-89603-500-X:335","volume-title":"DNA Damage and Repair, Volume 2: DNA Repair in Higher Eukaryotes","author":"LH Thompson","year":"1998","unstructured":"Thompson LH: Nucleotide excision repair: its relation to human disease. In: DNA Damage and Repair, Volume 2: DNA Repair in Higher Eukaryotes. (Eds: Nickoloff JA and Hoekstra MF), Humana, Totowa, NJ, 1998, pp. 335\u2013393"},{"key":"BF02940305_CR54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng953","volume":"32","author":"A-R Hartman","year":"2002","unstructured":"Hartman A-R, Ford JM: BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet 32: 180\u2013184, 2002","journal-title":"Nat Genet"},{"key":"BF02940305_CR55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/cbt.65","volume":"1","author":"R Takimoto","year":"2002","unstructured":"Takimoto R, MacLachlan TK, Dicker DT, Niitsu Y, Mori T, el-Deiry WS: BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation. Cancer Biol Ther 1: 177\u2013186, 2002 (comment 1: 187\u2013188, 2002)","journal-title":"Cancer Biol Ther"},{"key":"BF02940305_CR56","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0277-5379(86)90375-5","volume":"22","author":"E Kovacs","year":"1986","unstructured":"Kovacs E, Stucki D, Weber W, Muller H: Impaired DNA-repair synthesis in lymphocytes of breast cancer patients. Eur J Cancer Clin Oncol 22: 863\u2013869, 1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF02940305_CR57","first-page":"8465","volume":"61","author":"P Xiong","year":"2001","unstructured":"Xiong P, Bondy ML, Li D, Shen H, Wang LE, Singletary SE, Spitz MR, Wei Q: Sensitivity to benzo[a]pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res 61: 8465\u20138469, 2001","journal-title":"Cancer Res"},{"key":"BF02940305_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnci\/dji013","volume":"97","author":"DO Kennedy","year":"2005","unstructured":"Kennedy DO, Agrawal M, Shen J, Terry MB, Zhang FF, Senie RT, Motykiewicz G, Santella RM: DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 97: 127\u2013132, 2005","journal-title":"J Natl Cancer Inst"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02940305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02940305\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02940305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T18:59:24Z","timestamp":1558551564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02940305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["BF02940305"],"URL":"https:\/\/doi.org\/10.1007\/bf02940305","relation":{},"ISSN":["1219-4956"],"issn-type":[{"value":"1219-4956","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}